AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 7,460.00
-20.00 (-0.27%)
Feb 27, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 209.58 billion as of February 27, 2026. Its market cap has increased by 16.19% in one year.
Market Cap
209.58B
Enterprise Value
198.79B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,460.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 209.58B, a decrease of -50.49%. That is a compound annual growth rate of -9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 209.58B | -16.62% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 244.98B |
| Samil Pharmaceutical Co.,Ltd | 237.35B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Samjin Pharmaceuticals | 231.43B |
| Jeil Pharmaceutical Co.,Ltd | 230.67B |
| HLB Pharmaceutical | 217.80B |
| JW Lifescience | 205.48B |
| REYON Pharmaceutical | 201.75B |